Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine

被引:3
|
作者
Parajuli, Niraj [1 ]
Adhikary, Sabeena [1 ]
Karki, Anupama [1 ]
Tiwari, Sumida [2 ]
机构
[1] Bir Hosp, Natl Acad Med Sci, Dept Dermatol & Venereol, Kathmandu 44600, Nepal
[2] Bir Hosp, Natl Acad Med Sci, Dept Pathol, Kathmandu, Nepal
来源
关键词
DIAGNOSIS;
D O I
10.4269/ajtmh.20-0918
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cutaneous leishmaniasis (CL) can present with various skin lesions ranging from a single ulcer to diffuse multiple nodules. Here, we present a case of a 67-year-old man with a large erythematous well-defined indurated plaque over the left face for a duration of 4 months. A slit skin smear was performed, and it was stained with Giemsa stain which showed multiple amastigotes confirming the diagnosis of CL. Oral miltefosine was started at a dose of 150 mg/day but had to be stopped after 20 days as the patient developed diarrhea, bipedal edema, and renal impairment. This case emphasizes an uncommon variant of CL and the role of systemic treatment with oral miltefosine and its associated adverse effects.
引用
收藏
页码:643 / 645
页数:3
相关论文
共 50 条
  • [21] Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis
    C. Fischer
    A. Voss
    J. Engel
    Medical Microbiology and Immunology, 2001, 190 : 85 - 87
  • [22] Unusual form of cutaneous leishmaniasis: Erysipeloid form
    Mnejja, M.
    Hammami, B.
    Chakroun, A.
    Achour, I.
    Charfeddine, I.
    Chakroun, A.
    Turki, H.
    Ghorbel, A.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2011, 128 (02) : 95 - 97
  • [23] Post-traumatic erysipeloid cutaneous leishmaniasis
    Oezdemir, M.
    Cimen, K.
    Mevlitoglu, I. .
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (12) : 1292 - 1293
  • [24] Erysipeloid cutaneous Leishmaniasis: about a clinical observation
    El Kartouti, Abdeslam
    Elbenaye, Jalal
    Miloudi, Mouhcine
    PAN AFRICAN MEDICAL JOURNAL, 2015, 21
  • [25] Erysipeloid Leishmaniasis: A Case Series
    Ekmekci, Tugba R.
    Guder, Husna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [26] Refractory cutaneous leishmaniasis: Benefit of miltefosine
    Guerveno, C.
    Delavigne, K.
    Berry, A.
    Martin-Blondel, G.
    Delobel, P.
    MEDECINE ET MALADIES INFECTIEUSES, 2019, 49 (04): : 281 - 283
  • [27] Miltefosine for New World cutaneous leishmaniasis
    Soto, J
    Arana, BA
    Toledo, J
    Rizzo, N
    Vega, JC
    Diaz, A
    Luz, M
    Gutierrez, P
    Arboleda, M
    Berman, JD
    Junge, K
    Engel, J
    Sindermann, H
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) : 1266 - 1272
  • [28] Miltefosine to Treat Childhood Cutaneous Leishmaniasis
    Barba, P. J.
    Morgado-Carrasco, D.
    Quera, A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (08): : T827 - T831
  • [29] Oral cutaneous leishmaniasis mimicking carcinoma of tongue: A case report
    Joshi, A.
    Dhumal, S. B.
    Noronha, V
    Bonda, A.
    Pandey, A.
    Manickam, Raja D. K.
    Prabhash, Kumar
    INDIAN JOURNAL OF CANCER, 2014, 51 (03) : 401 - 402
  • [30] Efficacy of miltefosine for bolivian cutaneous leishmaniasis
    Soto, Jaime
    Rea, J.
    Balderrama, M.
    Toledo, J.
    Soto, J.
    Valda, L.
    Berman, Josh
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 286 - 286